Search

everythinglearnresearchcommunity

for

Search:↓

PRP is a promising alternative for alopecia areata due to its safety and patient satisfaction.

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Severe alopecia areata involves higher levels of certain immune cells, which can be normalized with betamethasone.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

JAK inhibitors show promise in treating difficult skin diseases.

Platelet-rich plasma injections can help treat hair loss in lupus patients.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

IL-15 helps maintain hair growth and protects the immune status of hair follicles.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Certain genetic variations can make people more likely to experience hair loss and low white blood cell count from azathioprine.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

Triamcinolone acetonide therapy for hair loss may cause a skin condition called linear lichen planus.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

PRP treatment reduces inflammation and increases interleukin-10 in alopecia areata patients.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Promising cancer treatments were found, but the manufacturer closed.

Photodynamic therapy was effective in treating multiple scalp basal cell carcinomas with minimal side effects and good cosmetic results.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.